28Feb/14

China Tacrolimus Market Investigation Report 2018 Forecasts – The International News Magazine

China Tacrolimus Market Investigation Report 2018 Forecasts
The International News Magazine
Tacrolimus, also named as “FK506″ and “FR900506″, was developed by Fujisawa Pharmaceutical Co., Ltd. (later became Astellas Pharma by merging with Yamanouchi Pharmaceutical Co., Ltd.). In June 1993, it was firstly approved to Japan with the trade 
Investigation Report on China Tacrolimus Market, 2009-2018PR Carbon (press release)

all 4 news articles »

28Feb/14

China Rituximab Market Investigation Report 2018 Forecasts – The International News Magazine

China Rituximab Market Investigation Report 2018 Forecasts
The International News Magazine
Rituximab (trade names “MabThera” by Roche, “Rituxan” by Genetech) is a chimeric monoclonal antibody against the protein CD20 approved in 1997 to treat tumor. It is very effective and shows good tolerance in the treatment of Bcell lymphoma. As people 

28Feb/14

Sentara Heart is enrolling heart failure patients in a national study of … – Daily Press (blog)

Sentara Heart is enrolling heart failure patients in a national study of
Daily Press (blog)
Sentara Heart Hospital in Norfolk is one of 40 sites testing an investigational parachute-shaped device to improve heart function. The PARACHUTE IV trial is for those with congestive heart failure in those who’ve suffered a heart attack. To date, 7

and more »